Conference Coverage

Biologics improve axial spondyloarthritis patients’ work performance


 

REPORTING FROM RHEUMATOLOGY 2018

Pages

Recommended Reading

Testing for latent tuberculosis infection
MDedge Family Medicine
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications
MDedge Family Medicine
Arthritis limits physical activity the most in the South
MDedge Family Medicine
Maternal biologic therapy does not affect infant vaccine responses
MDedge Family Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Family Medicine
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Family Medicine
TB in 2017: Good news and bad news
MDedge Family Medicine
MACE risk similar across arthritis subtypes
MDedge Family Medicine
Comorbid spondyloarthritis and fibromyalgia lower response to TNF inhibitors
MDedge Family Medicine
Ankylosing spondylitis diagnosis linked to self-harm attempts
MDedge Family Medicine

Related Articles